Cost-effectiveness of current and optimal treatment for schizophrenia

Andrews, Gavin, Sanderson, Kristy ORCID: https://orcid.org/0000-0002-3132-2745, Corry, Justine, Issakidis, Cathy and Lapsley, Helen (2003) Cost-effectiveness of current and optimal treatment for schizophrenia. British Journal of Psychiatry, 183. pp. 427-435. ISSN 1472-1465

Full text not available from this repository. (Request a copy)

Abstract

Background: This paper is part of a project to identify the proportion of the burden of each mental disorder averted by current and optimal interventions, and the cost-effectiveness of both. Aims: To use epidemiological data on schizophrenia to model the cost-effectiveness of current and optimal treatment. Method: Calculate the burden of schizophrenia in the years lived with disability (YLD) component of disability-adjusted life-years lost, the proportion averted by current interventions, the proportion that could be averted by optimal treatment and the cost-effectiveness of both. Results: Current interventions avert some 13% of the burden, whereas 22% could be averted by optimal treatment. Current interventions cost about AUS$200 000 per YLD averted, whereas optimal treatment at a similar cost could increase the number of YLDs averted by two-thirds. Even so, the majority of the burden of schizophrenia remains unavertable. Conclusions: Optimal treatment is affordable within the present budget and should be implemented.

Item Type: Article
Uncontrolled Keywords: sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > School of Health Sciences
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health
Depositing User: LivePure Connector
Date Deposited: 16 Jul 2021 00:18
Last Modified: 19 Oct 2023 03:02
URI: https://ueaeprints.uea.ac.uk/id/eprint/80603
DOI: 10.1192/bjp.183.5.427

Actions (login required)

View Item View Item